Complementary therapy use in patients with glioma: An observational study

Neurology

Volumn 75, Issue 24, 2010, Pages 2229-2235

  Heese, O ^a   Schmidt, M ^a   Nickel, S ^a   Berger, H ^b   Goldbrunner, R ^c   Tonn, J C ^c   Bahr O ^d   Steinbach, J P ^d   Simon, M ^e   Schramm, J ^e   Krex, D ^f   Schackert, G ^f   Reithmeier, T ^g   Nikkhah, G ^g   Loffler M ^b   Weller, M ^h   Westphal, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MINERAL; VITAMIN;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER GRADING; CLINICAL PRACTICE; DATA BASE; DIET THERAPY; EDUCATIONAL STATUS; FEMALE; GERMANY; GLIOMA; HOMEOPATHY; HUMAN; MAGIC; MAJOR CLINICAL STUDY; MALE; PHYTOTHERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; VISCUM ALBUM; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION;

EID: 78650829482     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820202c6     Document Type: Article

References (15)

1. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs and patterns of use. N Engl J Med 1993;328:246-252.
2. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative therapy use in the United States, 1990-1997: results of a follow-op national survey. JAMA 1998;280: 1569-1575.
3. Hauser SP. Unproven methods in oncology. Eur J Cancer 1991;27:1549-1551.
4. McFarland B, Bigelow D, Zani B, Newsom J, Kaplan M. Complementary and alternative medicine use in Canada and the United States. Am J Public Health 2002;92:1616-1618.
5. Cassileth BR. The social implications of questionable cancer therapies. Cancer 1989;63:1247-1250.
6. Cassileth BR, Lusk EJ, Suerry D. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324: 1180-1185.
7. Brown PD, Ballmann KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 2006;76:283-291.
8. Anderson SI, Tayler R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumors. J Neurosurg 1999;13:480-485.
9. Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER. Depression in patients with high-grade gli-oma: results of the glioma outcome project. Neurosurgery 2004;54:358-367.
10. Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic disease: use in brain tumor patients. Neurology 1999;55:617-622.
11. Burnstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative therapy medicine by woman with early-stage breast cancer. N Engl J Med 1999;340:1733-1739.
12. Fox S, Laws ER, Anderson F, Farace E. Complementary therapy use and quality of life in persons with high-grade gliomas. J Neurosci Nurs 2006;38:212-220.
13. Kuchler T, Bestmann B, Rappat S, Henne-Bruhns D, Wood-Dauphine S. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J Clin Oncol 2007;25:2702-2708.
14. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA 1999;282:651-656.
15. Begbie SD, Krestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. MJA 1996;165:545-548.